RENAL MEDULLARY BLOOD-FLOW - EFFECT OF VASOPRESSIN (AVP) AND THE VASCULAR ANTAGONIST D(CH2)5TYR (ME)AVP - VIDEOMICROSCOPIC STUDY IN RATS

被引：0
|
作者：
ZIMMERHACKL, LB
ROBERTSON, CR
JAMISON, RL
机构：
[1] UNIV MARBURG,DEPT PEDIAT,D-3550 MARBURG,FED REP GER
[2] STANFORD UNIV,STANFORD,CA 94305
来源：
RENAL PHYSIOLOGY AND BIOCHEMISTRY | 1986年 / 9卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
引用
收藏
页码：87 / 88
页数：2
相关论文
共 34 条
  • [21] EXPERIMENTAL WATER-INTOXICATION INDUCED BY DDAVP IN RAT, AND ITS PREVENTION WITH THE VASOPRESSIN ANTAGONIST D(CH2)5TYR(ET)VAVP
    LASZLO, FA
    BALASPIRI, L
    [J]. ACTA MEDICA HUNGARICA, 1986, 43 (03) : 333 - 339
  • [22] EFFECT OF V2-RECEPTOR-MEDIATED CHANGES ON INNER MEDULLARY BLOOD-FLOW INDUCED BY AVP
    KIBERD, B
    ROBERTSON, CR
    LARSON, T
    JAMISON, RL
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 253 (03): : F576 - F581
  • [23] THE VASOPRESSIN ANALOG [PMP1D-TYR(ET)2VAL4]AVP IS A MORE POTENT ANTAGONIST AT RENAL VASOPRESSIN RECEPTORS THAN [PMP1D-PHE2VAL4]AVP
    STASSEN, FL
    HECKMAN, G
    HUFFMAN, W
    STEFANKIEWICZ, J
    SULAT, L
    CROOKE, ST
    [J]. FEDERATION PROCEEDINGS, 1984, 43 (03) : 724 - 724
  • [24] [H-3] DESGLY-NH29-D(CH2)5[D-ILEU2,ILEU4]AVP - AN AVP V2 RECEPTOR ANTAGONIST RADIOLIGAND
    TRINDER, D
    STEPHENSON, JM
    GAO, X
    PHILLIPS, PA
    RISVANIS, J
    JOHNSTON, CI
    [J]. PEPTIDES, 1991, 12 (06) : 1195 - 1200
  • [25] QUANTITATIVE LIGHT MICROSCOPIC AUTORADIOGRAPHIC LOCALIZATION OF BINDING-SITES LABELED WITH [H-3] VASOPRESSIN ANTAGONIST D(CH2)5TYR(ME)VP IN THE RAT-BRAIN, PITUITARY AND KIDNEY
    VANLEEUWEN, FW
    VANDERBEEK, EM
    VANHEERIKHUIZE, JJ
    WOLTERS, P
    VANDERMEULEN, G
    WAN, YP
    [J]. NEUROSCIENCE LETTERS, 1987, 80 (02) : 121 - 126
  • [26] NEONATAL TREATMENT OF WISTAR RATS WITH THE VASOPRESSIN ANTAGONIST DP[TYR(ME)2]AVP INHIBITS POSTNATAL BODY AND BRAIN-DEVELOPMENT AND INDUCES DIABETES-INSIPIDUS
    SNIJDEWINT, FGM
    BOER, GJ
    [J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1987, 26 (02): : 200 - 201
  • [27] [I-125] [D(CH2)5,SAR7]AVP - A SELECTIVE RADIOLIGAND FOR V1-VASOPRESSIN RECEPTORS
    KELLY, JM
    ABRAHAMS, JM
    PHILLIPS, PA
    MENDELSOHN, FAO
    GRZONKA, Z
    JOHNSTON, CI
    [J]. JOURNAL OF RECEPTOR RESEARCH, 1989, 9 (01): : 27 - 41
  • [28] D(CH2)5TYR(ME)-[ORN8]VASOTOCIN, A POTENT OXYTOCIN ANTAGONIST, ANTAGONIZES PENILE ERECTION AND YAWNING INDUCED BY OXYTOCIN AND APOMORPHINE, BUT NOT BY ACTH-(1-24)
    ARGIOLAS, A
    MELIS, MR
    VARGIU, L
    GESSA, GL
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 134 (02) : 221 - 224
  • [29] THE EFFECT OF THE VASOPRESSIN ANTAGONIST D(CH2)5DTYRVAVP ON THE CARDIOVASCULAR-RESPONSES TO STIMULATION OF THE PARAVENTRICULAR NUCLEUS
    LAWRENCE, D
    CIRIELLO, J
    PITTMAN, QJ
    LEDERIS, K
    [J]. PROCEEDINGS OF THE WESTERN PHARMACOLOGY SOCIETY, 1984, 27 : 15 - 17
  • [30] 99mTc-LABELLED VASOPRESSIN ANALOGUE d(CH2) 5[D-Tyr(Et2), Ile4, Eda9] AVP AS A POTENTIAL RADIOPHARMACEUTICAL FOR SMALL-CELL LUNG CANCER (SCLC) IMAGING
    Gniazdowska, Ewa
    Kozminski, Przemyslaw
    Bankowski, Krzysztof
    [J]. 7TH INTERNATIONAL SYMPOSIUM ON TECHNETIUM AND RHENIUM - SCIENCE AND UTILIZATION, 2011, : 343 - 346
1234